[go: up one dir, main page]

AR106057A1 - COMPOSITION WITH ANTIVIRAL EFFECT, PHARMACEUTICAL COMPOSITION - Google Patents

COMPOSITION WITH ANTIVIRAL EFFECT, PHARMACEUTICAL COMPOSITION

Info

Publication number
AR106057A1
AR106057A1 ARP160102836A ARP160102836A AR106057A1 AR 106057 A1 AR106057 A1 AR 106057A1 AR P160102836 A ARP160102836 A AR P160102836A AR P160102836 A ARP160102836 A AR P160102836A AR 106057 A1 AR106057 A1 AR 106057A1
Authority
AR
Argentina
Prior art keywords
composition
pharmaceutical composition
antiviral effect
viral infection
treatment
Prior art date
Application number
ARP160102836A
Other languages
Spanish (es)
Inventor
Ammer Richard
Original Assignee
Medice Arzneimittel Pütter Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medice Arzneimittel Pütter Gmbh & Co Kg filed Critical Medice Arzneimittel Pütter Gmbh & Co Kg
Publication of AR106057A1 publication Critical patent/AR106057A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Una composición farmacéutica que comprende tirotricina, cloruro de benzalconio y/o benzocaína para su uso en la terapia antiviral o en el tratamiento de una infección por virus. Reivindicación 2: Composición farmacéutica para su uso en un procedimiento para el tratamiento de una infección viral de acuerdo con la reivindicación 1, en donde la infección viral es provocada por rinovirus, virus de la gripe y/o neumovirus. Reivindicación 5: Composición farmacéutica para su uso en un procedimiento para el tratamiento de una infección viral de acuerdo con una o varias de las reivindicaciones anteriores, que se trata de una pastilla para la garganta.A pharmaceutical composition comprising thyrotricin, benzalkonium chloride and / or benzocaine for use in antiviral therapy or in the treatment of a virus infection. Claim 2: Pharmaceutical composition for use in a method for the treatment of a viral infection according to claim 1, wherein the viral infection is caused by rhinovirus, influenza virus and / or pneumovirus. Claim 5: Pharmaceutical composition for use in a method for treating a viral infection according to one or more of the preceding claims, which is a throat pill.

ARP160102836A 2015-09-17 2016-09-16 COMPOSITION WITH ANTIVIRAL EFFECT, PHARMACEUTICAL COMPOSITION AR106057A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP15185764 2015-09-17

Publications (1)

Publication Number Publication Date
AR106057A1 true AR106057A1 (en) 2017-12-06

Family

ID=54151132

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP160102836A AR106057A1 (en) 2015-09-17 2016-09-16 COMPOSITION WITH ANTIVIRAL EFFECT, PHARMACEUTICAL COMPOSITION

Country Status (6)

Country Link
EP (1) EP3349741A1 (en)
AR (1) AR106057A1 (en)
DE (1) DE202016008745U1 (en)
EA (1) EA039000B1 (en)
UA (1) UA123054C2 (en)
WO (1) WO2017046312A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU101724B1 (en) * 2020-04-02 2021-10-04 Inflamed Pharma Gmbh Active ingredients for medical use
JP2023520524A (en) * 2020-04-02 2023-05-17 インフレイムド ファーマ ゲーエムベーハー medical active substance
EP4091608B1 (en) * 2021-05-21 2024-04-17 Medice Arzneimittel Pütter GmbH & Co. KG Composition with antiviral effect
EP4275681A1 (en) * 2022-05-10 2023-11-15 inflamed pharma GmbH Active compounds for medical use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19823319A1 (en) * 1998-05-26 1999-12-02 Karl Engelhard, Fabrik Pharm.- Praeparate Gmbh & Co. Kg Topical drug for the treatment of viral infections
DE19823318A1 (en) * 1998-05-26 1999-12-02 Karl Engelhard, Fabrik Pharm.- Praeparate Gmbh & Co. Kg Use of a drug containing tyrothricin to treat viral infections

Also Published As

Publication number Publication date
WO2017046312A1 (en) 2017-03-23
EA201890653A1 (en) 2018-08-31
DE202016008745U1 (en) 2019-06-21
EA039000B1 (en) 2021-11-19
EP3349741A1 (en) 2018-07-25
UA123054C2 (en) 2021-02-10

Similar Documents

Publication Publication Date Title
UY37581A (en) COMPOUNDS FOR THE TREATMENT OF HEPATITIS B VIRUS INFECTION
CL2020000685A1 (en) Substituted nucleosides, nucleotides and analogs thereof.
UY37252A (en) COMPOUNDS FOR HEPATITIS B VIRUS INFECTION TREATMENT
SV2018005610A (en) SUBSTITUTED OXOPIRIDINE DERIVATIVES
CO2019009215A2 (en) Hemi-sulfate nucleotide salt for the treatment of hepatitis C virus
MX2019009443A (en) METHODS TO TREAT INFLUENZA.
MX382221B (en) FORMULA IV COMPOUNDS FOR USE IN THE TREATMENT OF ARENAVIRIDAE AND CORONAVIRIDAE VIRUS INFECTIONS
MX2017008720A (en) DERIVATIVES AND METHODS FOR TREATMENT OF INFECTIONS BY HEPATITIS B.
CL2016002414A1 (en) Compounds derived from nucleosides, reverse transcriptase inhibitors pharmaceutical composition that comprises them and their use in the treatment of a hiv infection. pct
CR20190084A (en) USEFUL THERAPEUTIC COMPOUNDS FOR THE PROPHLACTIC OR THERAPEUTIC TREATMENT OF AN INFECTION WITH HIV VIRUS
CO2017002170A2 (en) Combination therapy to treat a paramyxovirus
GT201500020A (en) SULFAMOILARILAMIDAS AND ITS USE AS MEDICINES FOR THE TREATMENT OF HEPATITIS B
CL2016002971A1 (en) Combination.
CL2016000493A1 (en) Hcv polymerase inhibitors
CL2016000952A1 (en) Carboxamide derivatives and their use as medicines for the treatment of hepatitis b
EA201790597A1 (en) METHODS OF TREATING VIRAL INFECTIONS FILOVIRIDAE
MX2016009337A (en) DERIVATIVES OF AZEPANO AND METHODS TO TREAT INFECTIONS BY HEPATITIS B.
CR20130620A (en) 4-ARIL-N-FENIL-1,3,5-TRIAZIN-2-AMINAS CONTAINING A SULFOXIMINE GROUP
CL2018001226A1 (en) Dihydroimidazopirazinone derivatives used in cancer treatment
MX2017001752A (en) INDOLES FOR USE IN INFECTION WITH THE VIRUS OF THE FLU.
PE20180260A1 (en) METHODS AND KITS TO TREAT DEPRESSION
CL2014001599A1 (en) Compounds derived from nucleosides substituted in 4’-azido, 3’-fluoro or their salts, as inhibitors of vhc rna replication; pharmaceutical composition that includes them; and its use for the treatment or prophylaxis of hepatitis C virus (vhc) infection.
DOP2016000336A (en) ISOINDOLIN DERIVATIVES FOR USE IN THE TREATMENT OF A VIRAL INFECTION
MX389999B (en) MAST CELL STABILIZERS FOR THE TREATMENT OF HYPERCYTOKINEMIA AND VIRAL INFECTION
BR112017026061A2 (en) compound, use of a compound, and method of treating a viral infection

Legal Events

Date Code Title Description
FB Suspension of granting procedure